Add-on therapy for symptomatic treatment in adults w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line antianginal therapy.
Hypersensitivity. Parkinson's disease, parkinsonian symptoms, tremors, restless leg syndrome & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Not a curative treatment for angina attacks or as initial treatment for unstable angina, MI, pre-hospital phase or during 1st days of hospitalisation. Discontinue use if movement disorders eg, parkinsonian symptoms, restless leg syndrome, tremors, gait instability occur. Falls related to gait instability or hypotension. Positive result in anti-doping tests. May affect ability to drive & use machines. Moderate renal impairment. Avoid use during pregnancy. Not to be used during lactation. Childn <18 yr. Elderly >75 yr.